Extracellular vesicles enriched with miR-150 released by macrophages regulates the TP53-IGF-1 axis to alleviate

Suxia Zheng1, Maolei Gong2, Jing Chen1

  • 1Department of Cardiology, Linyi People's Hospital, Linyi, People's Republic of China.

Insights

Macrophage-derived extracellular vesicles transfer microRNA-150 (miR-150) to heart cells, reducing damage after myocardial infarction (MI). This miR-150 targets TP53, offering a potential therapy for heart attacks.

Area of Science:

  • Cardiovascular Biology
  • Extracellular Vesicles
  • Molecular Medicine

Background:

  • Myocardial infarction (MI) is a leading cause of global mortality.
  • Macrophage-derived extracellular vesicles (EVs) play a role in cellular responses to MI.
  • The precise mechanism of macrophage EV regulation in MI requires clarification.

Purpose of the Study:

  • To elucidate the mechanism by which macrophage-derived EVs regulate cellular responses in myocardial infarction.
  • To investigate the role of microRNA-150 (miR-150) in macrophage-derived EVs and its impact on cardiomyocytes.
  • To identify the molecular targets and signaling pathways involved in EV-mediated cardioprotection.

Main Methods:

  • Reverse transcription quantitative polymerase chain reaction (RT-qPCR) for miR-150 expression analysis.
  • Bioinformatics and dual luciferase reporter gene assays to determine miR-150 and TP53 interaction.
  • In vitro and in vivo gain- and loss-of-function experiments using EVs and MI models.
  • Histological analyses (HE, TUNEL) and biochemical assays (LDH, Western blot) to assess cardiomyocyte apoptosis and injury.

Main Results:

  • miR-150 expression was significantly downregulated in infarcted cardiac tissues of MI mice.
  • Macrophage-derived EVs successfully transferred miR-150 into cardiomyocytes, directly targeting and suppressing TP53.
  • EV-mediated miR-150 transfer suppressed cardiomyocyte apoptosis, reduced inflammatory infiltration, and alleviated MI in vivo by regulating the TP53-IGF-1 pathway.

Conclusions:

  • Macrophage-derived EV-miR-150 exerts a cardioprotective effect against MI-induced heart injury.
  • The mechanism involves the negative regulation of the TP53-IGF-1 signaling pathway.
  • EV-derived miR-150 represents a promising therapeutic target for myocardial infarction treatment.

Related Concept Videos